In 2007 the Foundation became the Fiscal Sponsor for a medical research program in Mali, Africa.  The clinical part of the Program involves the evaluation of an immune system enhancer called Low Dose Naltroxone as a way of preventing HIV positive individuals from subsequently developing AIDS symptoms. Participants in the clinical trials can also participate in monthly councils involving men and women discussing issues of intimate relationship, health and cultural mores that directly impact the spread of HIV. For current reports and links, please click here.